Publications
- Zkušenosti s léčbou abirateronem u pacienta s karcinomem prostaty2020 | First Faculty of Medicine
- Klinická onkologie2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Favorable prognostic significance of membranous β-catenin expression and negative prognostic significance of cytoplasmic β-catenin expression in pancreatic cancer2023 | First Faculty of Medicine, Third Faculty of Medicine
- Strategies for the treatment of urothelial carcinoma of the bladder2023 | First Faculty of Medicine
- Strategies for the treatment of urothelial carcinoma2023 | First Faculty of Medicine
- Enzalutamide and abiraterone in the treatment of patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy2023 | First Faculty of Medicine
- PARP inhibitors in treating metastatic castration-resistant prostate cancer2023 | First Faculty of Medicine
- Triplet in the treatment of hormone-sensitive prostate cancer2023 | First Faculty of Medicine
- Avelumab as a maintenance therapy for advanced urothelial bladder carcinoma2023 | First Faculty of Medicine
- Urachal yolk sac tumor penetrating the bladder as a diagnostic challenge: a case report and review of the literature2022 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
Loading network view...